ATLASPrestige Consumer Healthcare (PBH) earnings date: Nov 5, 2026
Prestige Consumer Healthcare (PBH) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026, before the open. Analysts expect EPS of $1.06.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on PBH
| Last price | $49.74 (+1.4%) |
|---|---|
| Normal 1-day range (±1σ) | ±1.7% |
| Earnings beat history | Beat the EPS estimate in 1 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Prestige Consumer Healthcare stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Prestige Consumer Healthcare reports on Nov 5, 2026. One email the day before, with ATLAS’s read on Prestige Consumer Healthcare. You can switch it off at any time.
Alert me before PBH reportsFree to start. Creating an account takes under a minute.
Notify me when Prestige Consumer Healthcare reports
Track PBH free Add Prestige Consumer Healthcare to a free ATLAS watchlist and see its next report date in one place.
PBH earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | $1.06 |
| Last report | Aug 6, 2026 · Beat |
| Beat rate (last 5 reports) | 1 of 5 (20%) |
| Average EPS surprise | -21.4% |
| Average move around a report | ±3.0% (last 5) |
| Sector | Healthcare · Drug Manufacturers - Specialty & Generic |
Prestige Consumer Healthcare earnings history: last 5 reports
Prestige Consumer Healthcare last reported on Aug 6, 2026: EPS of $0.98 against an estimate of $0.88 (+11.4% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 6, 2026 | $0.88 | $0.98 | +11.4% | Beat | +3.5% |
| May 13, 2026 | $1.39 | $1.23 | -11.5% | Miss | -8.9% |
| Feb 5, 2026 | $1.16 | $1.14 | -1.7% | In line | -1.0% |
| Nov 6, 2025 | $0.97 | $0.86 | -11.3% | Miss | +0.2% |
| Sep 10, 2025 | -$0.16 | -$0.31 | -93.8% | Miss | -1.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for PBH
See the fair value, the probability range and the earnings history of Prestige Consumer Healthcare on its ATLAS page.
Prestige Consumer Healthcare (PBH) stock analysisPlans from €3.99 a month.
Prestige Consumer Healthcare earnings: frequently asked questions
When does Prestige Consumer Healthcare (PBH) report earnings?
Prestige Consumer Healthcare is scheduled to report on Thursday, November 5, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for PBH?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is $1.06 per share (USD). Estimates can change before the report.
How often does PBH beat earnings estimates?
Of its last 5 reports with a recorded result, Prestige Consumer Healthcare beat the EPS estimate 1 times; the average surprise was -21.4%. Past results do not predict the next one.
How much does PBH move around earnings?
Over its last 5 reports the stock moved an average of 3.0% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did Prestige Consumer Healthcare beat earnings estimates last quarter?
Prestige Consumer Healthcare last reported on Aug 6, 2026: EPS of $0.98 against an estimate of $0.88 (+11.4% surprise), a beat.
How much does PBH usually move in a day?
On a normal trading day the ATLAS model puts PBH’s one-day range at about ±1.7%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer